Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001628280-24-011681

Chief Commercial Officer gave up 3,686 shares (to pay taxes)

  • Chief Commercial Officer acquired 58,631 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Verratti Mark Chief Commercial Officer 2024-03-14 Grant or award +58,631 308,370 D: show line 1 in the form
Verratti Mark Chief Commercial Officer 2024-03-15 Shares withheld for taxes −3,686 $21.16 $77,996 304,684 D: show line 2 in the form
Loading xslF345X05/wk-form4_1710794695.xml…